Bluesky Facebook Reddit Email

Use of glucagon-like peptide-1 agonists among individuals undergoing bariatric surgery in the US

08.27.25 | JAMA Network

DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.

About The Study: In this retrospective cohort study using a nationwide database, among a cohort of U.S. adults undergoing bariatric surgery, approximately 1 in 10 initiated a glucagon-like peptide-1 receptor agonist. Initiation was greater among women, those undergoing sleeve gastrectomy, and individuals with larger body mass index regain than among their counterparts.

Corresponding Author: To contact the corresponding author, Hemalkumar B. Mehta, MS, PhD, email hbmehta@jhu.edu .

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamasurg.2025.3089)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2025.3089?guestAccessKey=c16e37ce-0636-4bbc-9980-cef46a9e1c20&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082725

JAMA Surgery

Keywords

Article Information

Contact Information

Jim Michalski
JAMA Network
Jim.Michalski@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2025, August 27). Use of glucagon-like peptide-1 agonists among individuals undergoing bariatric surgery in the US. Brightsurf News. https://www.brightsurf.com/news/LRDE33M8/use-of-glucagon-like-peptide-1-agonists-among-individuals-undergoing-bariatric-surgery-in-the-us.html
MLA:
"Use of glucagon-like peptide-1 agonists among individuals undergoing bariatric surgery in the US." Brightsurf News, Aug. 27 2025, https://www.brightsurf.com/news/LRDE33M8/use-of-glucagon-like-peptide-1-agonists-among-individuals-undergoing-bariatric-surgery-in-the-us.html.